Scientific Management Review Board
Presentations
September 14-15, 2010
Overview of Translational Medicine and Therapeutics (TMAT) Working Group Charge (PDF - 1MB)
Arthur Rubenstein, M.B.B.Ch., Executive Vice President, University of Pennsylvania for Health System; Dean, School of Medicine, University of Pennsylvania
Development in Pharma R&D (PDF - 2.3MB)
Charles Baum, M.D., Ph.D., Senior Vice President, Pfizer
Cultivating Partnerships: Setting Goals and Defining Success (PDF - .6MB)
Stephen L. Eck, M.D., Ph.D., Vice President, Translational Medicine & Pharmacogenomics, Eli Lilly & Company
Scientific Discovery and Application are Driven by Technology and Tools (PDF - .6MB)
Mary L. Disis, M.D., F.A.C.P., Co-chair, T1 Translational Research Strategic Goal Committee, Clinical and Translational Science Awards, University of Washington
NCI's Experimental Therapeutics Program(NExT) (PDF - 1.7MB)
James H. Doroshow, M.D., Director, Division of Cancer Treatment and Diagnosis, NCI, NIH
NIH Scientific Management Review Board (PDF - .9MB)
Stephen L. Eck, M.D., Ph.D., Vice President, Translational Medicine & Pharmacogenomics, Eli Lilly & Company
GMP Facilities at the NIH Clinical Center (PDF - 1.5MB)
John I. Gallin, M.D., Director, NIH Clinical Center
NIH-RAID: Common Fund Translational Resources (PDF - 44KB)
Thomas Miller, Ph.D., M.B.A., Program Director, Office of Translational Research, National Institute of Neurological Disorders and Stroke, NIH
Bridging the Gap: Defining and Understanding the Necessary NIH Capabilities and Infrastructure (PDF - 1MB)
Susan E. Old, Ph.D., Acting Deputy Director, NIH Center for Translational Therapeutics
Substance Use, Abuse, and Addiction Working Group Report and Recommendations (PDF - 2.6MB)
William Roper, M.D., M.P.H., Dean, School of Medicine and Vice Chancellor for Medical Affairs, University of North Carolina; CEO, UNC Health Care System
March 10, 2010
Deliberating Organizational Change and Effectiveness Working Group Update (PDF - 3MB)
William Brody, M.D., Ph.D., President, Salk Institute for Biological Studies
NIH Intramural Research Program Working Group Update (PDF - 3.7MB)
Arthur Rubenstein, M.B.B.Ch., Executive Vice President, University of Pennsylvania for Health System and Dean, University of Pennsylvania School of Medicine
Substance Use, Abuse, and Addiction Working Group Update (PDF - 3.8MB)
William Roper, M.D., M.P.H., Dean, School of Medicine and Vice Chancellor for Medical Affairs, University of North Carolina; CEO, UNC Health Care System
Patterns of Successful Organizational Change (PDF - .2MB)
Hal G. Rainey, School of Public and International Affairs, The University of Georgia
Sergio Fernandez, School of Public and International Affairs, Indiana University
November 13, 2009
Scientific Management Review Board (PDF - 1.2MB)
Raynard S. Kington, M.D., Ph.D., Deputy Director, NIH
Vision for the NIH and the Role of the SMRB (PDF - 1.9MB)
Francis Collins, M.D., Ph.D., Acting Director, NIH
Substance Use, Abuse, and Addiction Research Working Group (PDF - .8MB)
William Roper, M.D., M.P.H., Dean, School of Medicine and Vice Chancellor of Medical Affairs, University of North Carolina; CEO, UNC Health Care System
Deliberating Organizational Change and Effectiveness Working Group (PDF - .3MB)
Thomas Kelly, M.D., Ph.D., Director, Sloan-Kettering Institute and Memorial Sloan-Kettering Cancer Center
NIH Intramural Research Program Working Group (PDF - .7MB)
Arthur Rubenstein, M.B.B.Ch., Executive Vice President, University of Pennsylvania for Health System and Dean, University of Pennsylvania School of Medicine
September 23, 2009
Alcohol: Systems Biology (PDF - .5MB)
Alcohol Health and Social Problems: Policy Research Status and Opportunities (PowerPoint - .8MB)
Alcohol Treatment (PDF - .2MB)
Alcohol Use in the United States: A Behavioral Perspective (PDF - .7MB)
Consequences of Alcohol on End-Organ Pathology in Liver (PDF - 1.4MB)
Linda J. Porrino, Wake Forest University School of Medicine (PDF - .3MB)
Medical Complications Alcohol and Drug Abuse (PowerPoint - .5MB)
Merger of NIH-NIDA & NIH-NIAAA?: Systems Science (PowerPoint - 2.4MB)
NIDA Is Wonderful (PDF - .1MB)
Substance Abuse: Challenges and Opportunities (PowerPoint - 6.7MB)
Treatment Provider Perspective (PDF - 99KB)
Treatment/Relapse (PDF - .1MB)
Waggoner Center for Alcohol and Addiction Research (PDF - 1MB)
Why Families Support the Merger of the National Institute on Drug Abuse (PDF - .8MB)
April 27-28, 2009
Scientific Management Review Board (PDF - 1.1MB)
Raynard S. Kington, M.D., Ph.D., Acting Director, NIH
Federal Advisory Committee Act and the Scientific Management Review Board (PDF - .3MB)
Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy, NIH
Notes for the Scientific Management Review Board (PDF - 1.9MB)
Gretchen H. Weaver, Senior NIH Ethics Counsel, Office of the General Counsel, Ethics Division, Department of Health and Human Services
Goals of Meeting (PDF - 31KB)
Norman Augustine, Chairman, Scientific Management Review Board
Scientific Opportunities and Emerging Public Health Issues at the NIH: A View from NIAID (PDF - 10.8MB)
Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, NIH
The Search for a "Better Way:" The Evolution Leading to the SMRB (PDF - 1.7MB)
Marc Smolonsky, Director, Office of Legislative Policy and Analysis, NIH
NIH Central Services, Cost Drivers and the Role of the Clinical Center (PDF - .5MB)
Colleen Barros, Deputy Director, Office of Management, NIH
Enhancing the Vitality of the National Institutes of Health (PDF - 2.8MB)
Debra Lappin, Senior Vice President, B&D Consulting
American Recovery and Reinvestment Act (ARRA)—Impact of Economic Stimulus on NIH (PDF - 1MB)
Lawrence A. Tabak, D.D.S., Ph.D., Director, National Institute of Dental and Craniofacial Research and Acting Deputy Director, NIH
April 28, 2009
Evolution of NIAAA and NIDA: Science, Structure, and Function (PDF - .9MB)
Lawrence A. Tabak, D.D.S., Ph.D., Director, National Institute of Dental and Craniofacial Research and Acting Deputy Director, NIH
NIDA: Bringing the full power of science to bear on Drug Abuse & Addiction (PDF - 2.4MB)
Nora D. Volkow, M.D., Director, National Institute on Drug Abuse, NIH
The National Institute on Alcohol Abuse and Alcoholism (PDF - 3.1MB)
Kenneth R. Warren, Ph.D., Acting Director, National Institute on Alcohol Abuse and Alcoholism, NIH
The NIH Intramural Research Program: Taking Its Place for the Future (PDF - .7MB)
Michael M. Gottesman, M.D., Deputy Director, Office of Intramural Research, NIH
The NIH Clinical Center (PDF - 4.7MB)
John I. Gallin, M.D., Director, Clinical Center, NIH
Next Steps (PDF - .1MB)
Norman Augustine, Scientific Management Review Board Chair
Social Media Links